Glenmark Pharmaceuticals Ltd.’s licensing pact with AbbVie Inc. for its blood cancer drug is boosting optimism over Indian biotechnology stocks, with some brokerages calling it the largest such deal …
Glenmark-AbbVie Deal Lifts Optimism on India’s Biotech Stocks
view original post